DO-BO

Podcasts

This is a repost of a popular episode of MAP – Market Access Podcast, from December 15th 2021. Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board. In this wide ranging […]

This is a repost of a popular episode of MAP – Market Access Podcast, from April 15th 2023. All patients within all populations should have access to high quality medications that improve their health outcomes regardless of race, ethnicity, socio-economic status or any other individual factors, wrote Dr. Utibe R. Essien in an Jama article 2021. But how does […]

This is a repost of a popular episode of MAP – Market Access Podcast, from October 1st 2022. Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next years. Germany has started by implementing digital health applications (“DIGAs”) and is currently on its way to […]

This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023. Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important […]

Join us on the latest episode of MAP – the Market Access Podcast – where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs). In this episode, they unpack how healthcare’s carbon footprint and […]

This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023.  Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design […]

This is a repost of a popular MAP, Market Access Podcast, from January 2023.  A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also […]

In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some […]

Join us on the latest episode of MAP – the Market Access Podcast – hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management. Explore […]

Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes […]

Tune in to the new episode of the Market Access Podcast (MAP), where Dr. Stefan Walzer, a pioneer in Market Access 4.0, explores groundbreaking solutions and innovative technologies shaping the future of healthcare reimbursement. Discover how AI-based platforms like Q-Bo and Wafle are revolutionizing health care trainings with all stakeholders. Special guest Rodrigo Silva shares […]

In the latest episode of MAP – the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape.  Discover how AI is […]

What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond. In […]

By signing up to Healthmind you’ll always have the latest and most relevant news articles within Healthcare & Pharma industry close at hand – sign up here We are so excited to announce the launch of our news feed: Healthmind! With the rapid pace of change in healthcare and pharmaceuticals, staying informed is crucial for […]

In the newest episode of MAP – the Market Access podcast, experts Tara Cowling and Jody Filkowski unpacks the complexities and nuances of Canada’s market access for pharmaceuticals and medical devices. From regulatory hurdles to intricate reimbursement pathways, they shed light on what it takes to successfully navigate this diverse and challenging landscape. Whether you’re […]

What role will AI & VR transformations play in the future? Tune in to this fascinating episode of the Market Access Podcast to hear as our special guest, Glib Kutepov, CEO and founder of Modulate, shares his expertise.  Glib uncovers the potential of generative AI and neural networks in revolutionizing market access strategies and highlights […]

Let's bring amazing solutions to the global markets together